Atlassian (NasdaqGS:TEAM) Falls 13% Amid Q2 Revenue Rise To US$1,286 Million
Take a closer look at Atlassian's potential here.
The last five years have seen Atlassian achieve a commendable total return of 86.70%, combining share price appreciation and dividends. Despite its unprofitability, Atlassian has shown resilience with a consistent revenue increase, such as the Q4 FY 2024 report announcing full year revenue at US$4.36 billion, up from US$3.53 billion. This growth trajectory aligns with its revenue forecast to outpace the broader US market. However, the company appears expensive based on its Price-To-Sales Ratio compared to industry averages, which might concern potential investors.
Noteworthy events that could have contributed to the performance include Atlassian's multi-year collaboration with Amazon Web Services announced in December 2024, aiming to advance cloud migration for enterprise customers. The extensive share buyback program, with 4.64 million shares repurchased, underscores efforts to enhance shareholder value, even as executive changes such as the appointment of Brian Duffy as Chief Revenue Officer indicate a focus on refining revenue strategies. These elements combined may explain the substantial long-term shareholder returns.
Learn how Atlassian's intrinsic value compares to its market price with our detailed valuation report.
Gain insight into the risks facing Atlassian and how they might influence its performance—click here to read more.
Got skin in the game with Atlassian? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGS:TEAM.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
US-EU trade deal impacts on pharma industry more 'manageable' than expected
A 15% import tariff on pharmaceutical goods from the European Union to the US is going to have a lesser impact on the pharmaceutical industry than Wall Street feared. Big pharmaceutical stocks like Pfizer (PFE), Eli Lilly (LLY), and Johnson & Johnson (JNJ) rose slightly, by about 1%, in trading Thursday after the trade deal was announced, putting to rest concerns of tariffs threatened as high as 200% previously by President Trump. "The two regions have established a 15% tariff cap on imported drugs from EU to the US. This is being viewed by most as both manageable and below the 20%+ rate many expected," wrote Mizuho's healthcare expert Jared Holz in a note to clients Thursday. The deal outlined by the US and EU has multiple parts that impact the pharmaceutical industry, with some clarity still needed. The first is levying either the 15% tariff or the Most Favored Nation (MFN) pricing, whichever is higher, on pharma drugs manufactured in the EU. This puts more emphasis on President Trump's efforts to equalize US drug costs to the lower prices seen in the EU and other developed nations and also impacts a smaller portion of products, as pharma executives have emphasized that most of the branded drugs sold in the US are made in the US. But questions remain on whether the finalize products, or some components, will be taxed. "The United States commits to apply the higher of either the US MFN tariff rate or a tariff rate of 15 percent, comprised of the MFN tariff and a reciprocal tariff, on originating goods of the European Union," according to the White House statement. The second part of the deal is that, as of Sept. 1, the US will enforce MFN pricing on generics and "chemical precursors." The latter refers to active pharmaceutical ingredients, which are the key chemical compounds in any drug. They are cheaper to mass-produce overseas, largely in Asia or Ireland. Experts say that prices for generics, which account for a majority of prescriptions filled in the US, are already low. "The administration is, for the time being, focusing Most Favored Nations pricing on generic products — hoping to peg US prices to that of other countries. Given the already lower cost of generic medicines and net price paid domestically, see the financial ramifications here as more limited than not. Have to look deeper at what precise drugs will be subject to this regulation but for now, not a strategy we see as stifling the industry/major players," Mizuho's Holz said. Its why big generics players, like Teva (TEVA), saw their stocks also rise on the news — up more than 4% Thursday. UBS analyst Ashwani Verma called the trade deal a positive for drugmakers, in a note to clients Thursday. The deal also left wiggle room for additional items: "The United States and the European Union agree to consider other sectors and products that are important for their economies and value chains for inclusion in the list of products for which only the MFN tariffs would apply," according to the White House statement. J.P. Morgan analyst Chris Schott told clients Thursday that clarity on details — including which components are chosen and how the tariffs are levied — as well as the pending results of an investigation by the US Department of Commerce Bureau of Industry and Security, will determine the final impact. In addition, Schott noted that many companies have already stocked up on products in advance of the expected tariff deal, and have inventory through mid-2026. "In the near-term, we see inventory stocking as largely limiting the impact of tariffs through mid-to-late 2026 or longer in some cases," Schott said. Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Click here for in-depth analysis of the latest health industry news and events impacting stock prices
Yahoo
21 minutes ago
- Yahoo
As Cava, Chipotle Sink, Left-for-Dead Rivals Stage Comeback
(Bloomberg) -- As inflation and a slowing economy start taking their toll on the US consumer, the pain is mounting across the restaurant industry. Shares of Chipotle Mexican Grill Inc., Cava Group Inc. and Sweetgreen Inc. — hot names in what had been a booming fast-casual segment — have each sunk around 20% or more since reporting lackluster second-quarter earnings. Even McDonald's Corp., among the most resilient of fast-food standbys, is barely keeping pace with the broader market. Why New York City Has a Fleet of New EVs From a Dead Carmaker Trump Takes Second Swing at Cutting Housing Assistance for Immigrants Chicago Schools Seeks $1 Billion of Short-Term Debt as Cash Gone Neom's Desert Ski Resort Strains Saudi Prince's $1.5 Trillion Plan We Need a Reality Check on Crime, Safety and Transit All of which makes the robust earnings and stock rallies coming from a slightly more expensive segment of the restaurant world surprising. Casual-dining chains are posting strong sales growth that is suddenly rekindling investor interest in a business that many had condemned in recent years to a slow demise. Wall Street is taking notice: shares of Cheesecake Factory Inc. — known for massive portions and over-the-top decor — are up nearly 29% this year, more than tripling the S&P 500 Index. Other names, such as Chili's owner Brinker International Inc., have also delivered double-digit gains. For many of the casual-dining brands, it's been a story of small adjustments. Long seen by consumers as far too expensive for what they offered — how much better is it, really, to sit down (and pay a tip) at a Chili's rather than grab a meal at Chipotle? — they have made incremental but well-targeted changes that drew diners looking to get maximum value for their money: trimming prices, spiffing up interiors and pouring money into marketing. Some are also working hard to tempt clients with more expensive items such as drinks and desserts once they're through the door. Even Applebee's, which has struggled with years of weak sales, seems to be making the formula work. In March, it relaunched a promotion featuring two entrees and an appetizer for $25. The response was swift, as diners flocked to sample honey-glazed chicken and six-ounce sirloin steaks. Sales climbed last quarter for the first time since 2023. Telling inflation-weary diners how much their night out would cost was key, said John Peyton, CEO of Dine Brands Global Inc., which owns Applebee's. 'That was sort of a moment where you bonk your head and you say: 'Wow, we had the answer all along,'' Peyton said in an interview. Trading Up The shift is, in some ways, a microcosm of the nation's economic moment. While growth continues apace, the job market has become more fragile and wage gains have largely stalled. Meanwhile, inflation has slowed from its blistering post-pandemic pace but continues grinding higher. Although consumers haven't pulled back on spending in a meaningful way, many are trying to make their dollars go further, boosting the appeal of a $25 night out at Applebee's versus, say, a $17 salad from Sweetgreen. 'You would typically assume or expect casual dining to suffer in this environment because it is a higher ticket,' said Eric Gonzalez, an analyst at Keybanc Capital Markets Inc. However, 'people have figured out that they can get a decent meal at a casual-dining restaurant for not quite what it costs to eat at McDonald's or one of the fast-food guys.' It's a trend that Chili's executives sensed more than a year ago, when they spotted irate fast-food diners posting receipts for pricey meals on social media. Sensing an opportunity, the once-beleaguered chain launched a combo offering a burger, fries and a drink — on top of unlimited chips and salsa — for $10.99 (a medium Big Mac Meal with fries and a beverage, by comparison, was listed for $9.69 at a Chicago McDonald's in August). 'One of the promises of fast food is that it's convenient and that it's a really great value,' said Kevin Hochman, chief executive officer of Chili's owner Brinker. 'I think people were feeling like the promise was being broken.' The impact on Brinker's top line wasn't long in coming. Same-store sales have grown by double digits, including a 24% gain in the latest quarter. The company's shares are up almost 15% this year. Hochman also noted that each Chili's patron spends, on average, $22 before tax and tip — suggesting that many are adding on more expensive offerings, even if they initially came for an advertised deal. Chili's has taken other steps aimed at enhancing diners' experience, pouring some $100 million into repairing restaurants, cutting down 25% of its menu to turn around orders faster and adding more workers to stores to improve service. The chain has also upgraded its meals and simplified how some products are made to boost consistency. Of course, fortunes can shift quickly. Shares of Cracker Barrel Old Country Stores Inc. tumbled on Thursday amid a wave of negative social media posts surrounding a recently unveiled change to the company's logo. And some limited-service brands are managing just fine. Drive-through coffee chain Dutch Bros Inc. grew same-store sales even faster than the prior quarter, while Taco Bell managed to lift traffic once again with a combination of novel limited-time offers and a dirt-cheap value menu. Some of the chains that have struggled, meanwhile, are now fighting back. Sweetgreen, for example, has launched $13 limited-time offers and a new loyalty program featuring some discounts. Still, many on Wall Street are betting that the recent weakness in some of the companies' shares will continue. Short interest as a percentage of float — the number of shares sold short as a proportion to the total available for trading — for Sweetgreen and Jack in the Box Inc. recently stood at above 20%, according to data from S3 Partners LLC. That compares to 15% and 8.6% a year ago, respectively. Other stocks in the category, including Shake Shack Inc., have also attracted heavy bearish bets. At the same time, there's little indication that the casual-dining chains are resting on their laurels. In April, Chili's added another option to its $10.99 promotion. Applebee's is hawking a new burger, drink and fries deal starting at $9.99. Red Robin Gourmet Burgers Inc. has a similar offer, which it has said is driving traffic. 'It wasn't long ago that everybody wanted to be the Chipotle of this or the Chipotle of that,' said Dan Ahrens, overseer of the AdvisorShares Restaurant ETF. 'Now, they're emulating the casual-dining experience.' --With assistance from William Selway. (Updates prices and chart, adds context and news on Cracker Barrel in paragraph 15.) Foreigners Are Buying US Homes Again While Americans Get Sidelined Volkswagen EVs Outsell Tesla in Europe a Decade After Dieselgate What Declining Cardboard Box Sales Tell Us About the US Economy Women's Earnings Never Really Recover After They Have Children Survived Bankruptcy. Next Up: Cultural Relevance? ©2025 Bloomberg L.P. Sign in to access your portfolio
Yahoo
21 minutes ago
- Yahoo
Innovative Solutions Announces Successful Use of DarcyIQ in Strategic Collaboration Agreement with AWS Focused on Smaller Businesses
A Premier Tier AWS Partner with a specialized focus on SMBs, Innovative Solutions is distinctly positioned to help growing businesses leverage the power of AWS ROCHESTER, N.Y., Aug. 21, 2025 /PRNewswire/ -- Innovative Solutions, a Premier Tier AWS Partner and global leader of Generative AI, Data, and Cloud services solutions for growing businesses, today announced that the company has achieved several important milestones in its Strategic Collaboration Agreement (SCA) with Amazon Web Services (AWS) focused on helping small and medium businesses (SMBs) achieve meaningful growth. Innovative Solutions was a launch partner for the AWS SMB Competency in January 2024, and as such, is one of a small subset of AWS partners uniquely positioned to help emerging and growing companies on AWS. Uniquely, Innovative utilized DarcyIQ, an agentic AI consulting platform that accelerates sales, to rapidly reach, inspire, and assist SMBs with growing on the AWS cloud. Using DarcyIQ, Innovative has tripled new customer acquisition in the SMB segment in the last 8 months. "Innovative Solutions was born out of the SMB space and our mission is to help every SMB leverage the power of AWS," added Justin Copie, CEO of Innovative Solutions. "Right now, SMB cloud spend is expected to reach $578B over the next two years, and at the same time, the overwhelming majority (91%) of small business technology transactions are facilitated or influenced by a partner. We aim to be the trusted partner that helps small and midsize businesses navigate the AWS ecosystem for their maximum benefit." As part of its SCA, AWS has co-invested with Innovative Solutions in go-to-market activities in the SMB space as well as initiatives to support SMB customers on AWS. With AWS's support, Innovative has expanded its second headquarters in Boca Raton, FL in support of this strategic collaboration, brought additional products to market, and built new technology that allows growing businesses to buy AWS services instead of having to build from scratch. "DarcyIQ helped us build upon Innovative's AWS SMB and Generative AI competencies," said Travis Rehl, CTO, Innovative Solutions. "We are clearly at the forefront of building the products and solutions that will continue to make genAI and genBI initiatives accessible to businesses of all sizes on AWS." Innovative Solutions has specialized expertise in working with companies in manufacturing, retail, financial services, life sciences/healthcare, and leverages DarcyIQ to perform discovery, analyze customer buying intent, and ultimately generate Statements of Work in minutes. For more information about Innovative Solutions, visit About Innovative SolutionsInnovative Solutions is a leading provider of cloud services for growing businesses. With more than three decades of experience and a 99.7% customer retention rate, Innovative Solutions has deep expertise in Generative AI, Machine Learning, Data and Analytics, Cloud Modernization, Cloud Migrations, and Managed Cloud Services. As a Premier Tier AWS Partner with Generative AI competency, Innovative Solutions is at the forefront of helping businesses leverage the power of the cloud and AI to drive growth and innovation. For more information about Innovative Solutions, visit and for more information about DarcyIQ, visit View original content to download multimedia: SOURCE Innovative Solutions Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
